Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma

Table 4

Association between CXCR3%, PD-L1+CXCR3+%, PD-1+CXCR3+%, IL-19, and laboratory and clinicopathological criteria in lymphoma. LDH: lactate dehydrogenase; Hb: hemoglobin; pre-T: pretherapy. identifies significant differences at ; identifies highly significant differences at .

	Pre-T CXCR3+%		Pre-T PDL-1+CXCR3+%		Pre-T PD-1+CXCR3+%		Pre-T IL-19
		value		value		value		value
Age	-0.028	0.805	-0.023	0.843	0.003	0.978	0.025	0.827
Hb g/dL	-0.214	0.060	-0.254	0.025	-0.110	0.339	-0.057	0.621
L D H U/L	0.344	0.002	0.375	0.001	0.315	0.005	0.349	0.002
Albumin g/dL	-0.269	0.017	-0.326	0.004	-0.337	0.003	-0.124	0.278
Ascites	0.017	0.884	0.057	0.621	0.018	0.875	0.116	0.311
Lymphedema	0.452	<0.001	0.445	<0.001	0.283	0.012	0.426	<0.001
Hypertension	-0.120	0.294	-0.083	0.472	0.077	0.501	0.085	0.462
Diabetes	0.093	0.418	0.172	0.132	0.215	0.059	0.149	0.192
BCR-ABL	0.262	0.020	0.271	0.016	-0.044	0.702	0.135	0.240
Hepatomegaly	0.464	<0.001	0.398	<0.001	0.335	0.003	0.362	0.001
Splenomegaly	0.348	0.002	0.268	0.018	0.172	0.132	0.231	0.042
Stage	0.498	<0.001	0.437	<0.001	0.344	0.002	0.406	1
General lymphadenopathy	0.362	0.001	0.304	0.007	0.170	0.137	0.239	0.035
Recurrence	0.645	<0.001	0.676	<0.001	0.310	0.006	0.641	<0.001